This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perea, S. E. Articles by Alonso, D. F. Search for Related Content PubMed PubMed Citation Articles by Perea, S. E. Articles by Alonso, D. F.

Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2)

¹ Laboratory of Molecular Oncology, Division of Pharmaceuticals, Center for Genetic Engineering and Biotechnology, Havana, Cuba; and ² Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, Argentina

Protein Kinase (casein kinase 2, CK2) is a serine-threonine kinase that is frequently dysregulated in many human tumors. Therefore we hypothesized that peptides capable of binding to the CK2 acidic domain may exhibit potential anticancer properties. By screening a random cyclic peptide phage display library, we have identified a novel peptide, P15, that abrogated CK2 phosphorylation by blocking the substrate in vitro. To verify its potential antineoplastic effect, P15 was fused to the cell-penetrating peptide derived from the HIV-Tat protein. Interestingly, P15-Tat induced apoptosis as evidenced by rapid caspase activation and cellular cytotoxicity in a variety of tumor cell lines. Furthermore, direct injection of P15-Tat into C57BL6 mice bearing day 7-established solid tumors, resulted in substantial regression of the tumor mass. Our findings describe a new proapoptotic cyclic peptide that blocks the CK2 phosphorylation and exhibits antitumor effect in vivo, indicating that the P15 peptide may potentially be used clinically to treat solid tumors or as an adjuvant for cancer therapy.

This article has been cited by other articles:

				M.-K. Kwon, J.-O. Nam, R.-W. Park, B.-H. Lee, J.-Y. Park, Y.-R. Byun, S.-Y. Kim, I.-C. Kwon, and I.-S. Kim Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3 Mol. Cancer Ther., June 1, 2008; 7(6): 1514 - 1522. [Abstract] [Full Text] [PDF]

				J.-L. Su, K.-P. Lai, C.-A. Chen, C.-Y. Yang, P.-S. Chen, C.-C. Chang, C.-H. Chou, C.-L. Hu, M.-L. Kuo, C.-Y. Hsieh, et al. A Novel Peptide Specifically Binding to Interleukin-6 Receptor (gp80) Inhibits Angiogenesis and Tumor Growth Cancer Res., June 1, 2005; 65(11): 4827 - 4835. [Abstract] [Full Text] [PDF]

				K. Yamane and T. J. Kinsella CK2 Inhibits Apoptosis and Changes Its Cellular Localization Following Ionizing Radiation Cancer Res., May 15, 2005; 65(10): 4362 - 4367. [Abstract] [Full Text] [PDF]

				J. W. Slaton, G. M. Unger, D. T. Sloper, A. T. Davis, and K. Ahmed Induction of Apoptosis by Antisense CK2 in Human Prostate Cancer Xenograft Model Mol. Cancer Res., December 1, 2004; 2(12): 712 - 721. [Abstract] [Full Text] [PDF]